Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Unihealth HospitalsNSE:UNIHEALTH -0.24%58 Altman Z-Score is 15.13 as of Aug. 07, 2026, which is 208% above its 10-year median of 4.91. GuruFocus rates NSE:UNIHEALTH with a GF Score™ of 58/100 and a GF Value™ of ₹382.53 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 656 Healthcare Providers & Services companies, Unihealth Hospitals ranks better than 94.66% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 14.45 is strong.
Unihealth Hospitals has a Altman Z-Score of 15.13, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Unihealth Hospitals's Altman Z-Score or its related term are showing as below:
NSE:UNIHEALTH'
s Altman Z-Score Range Over the Past 10 Years
Min: 4.44 Med: 4.91 Max: 14.45
Current: 14.45
During the past 7 years, Unihealth Hospitals's highest Altman Z-Score was 14.45. The lowest was 4.44. And the median was 4.91.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Unihealth Hospitals Altman Z-Score Related Terms
Unihealth Hospitals Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Unihealth Hospitals's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:UNIHEALTH vs HCA, THC, DVA: Altman Z-Score Comparison
For the Medical Care Facilities subindustry, Unihealth Hospitals's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unihealth Hospitals Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Unihealth Hospitals's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Unihealth Hospitals's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Unihealth Hospitals's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.4983
+
1.4
*
0.25
+
3.3
*
0.19
+
0.6
*
21.7193
+
1.0
*
0.5193
=
15.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Unihealth Hospitals (NSE:UNIHEALTH) has a Altman Z-Score of 15.13 as of Aug. 07, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Unihealth Hospitals and its competitors. This is 208% above median its historical median of 4.91. Over the past decade, Unihealth Hospitals' Altman Z-Score has ranged from 4.44 to 14.45. According to the industry distribution chart, Unihealth Hospitals ranks #35 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 5.3%.
Is Unihealth Hospitals' Altman Z-Score too high?
Unihealth Hospitals' current Altman Z-Score of 15.13 is 208% above median its 10-year median of 4.91. Over the past 10 years, this metric has ranged from a low of 4.44 to a high of 14.45. The Healthcare Providers & Services industry median Altman Z-Score is 2.45. Unihealth Hospitals' value of 15.13 is 518.8% above this industry median. Based on the distribution chart, Unihealth Hospitals ranks #35 out of 656 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Unihealth Hospitals has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unihealth Hospitals' Altman Z-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Unihealth Hospitals ranks #35 out of 656 companies for Altman Z-Score. This places Unihealth Hospitals in the top 5% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.45. Unihealth Hospitals' value of 15.13 is 518.8% above this benchmark. Historically, Unihealth Hospitals' own Altman Z-Score has ranged from 4.44 to 14.45 over the past decade. While the company's 10-year median is 4.91 vs. the industry median of 2.45, Unihealth Hospitals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.45, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unihealth Hospitals's current Altman Z-Score of 15.13 is 518.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Unihealth Hospitals and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unihealth Hospitals's current Altman Z-Score is 15.13, which is 208% above median its own 10-year median of 4.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unihealth Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Unihealth Hospitals (NSE:UNIHEALTH) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹382.53, compared to a current price of ₹777.50 — trading 103.3% above its estimated fair value. The current Altman Z-Score is 15.13, which is 208% above median its 10-year median of 4.91 and 518.8% above the Healthcare Providers & Services industry median of 2.45. Unihealth Hospitals' overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Unihealth Hospitals (NSE:UNIHEALTH), the current Altman Z-Score is 15.13 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unihealth Hospitals (NSE:UNIHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Unihealth Hospitals stock appears to be overvalued.
The current stock price of ₹777.50 is trading 103.3% above its estimated GF Value™ of ₹382.53.
GuruFocus considers Unihealth Hospitals to be Significantly Overvalued.
Key valuation signals for NSE:UNIHEALTH:
Altman Z-Score: 15.13 (208% above median its 10-year median of 4.91)
GF Value™: ₹382.53 vs. price of ₹777.50 (103.3% above fair value)
Industry Position: 518.8% above the Healthcare Providers & Services median (#35 of 656)
No single metric tells the full story. See the NSE:UNIHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unihealth Hospitals Ltd is a healthcare service provider based out of India and has an operational presence in multiple countries across the African continent. The company is predominantly engaged in the business of medical tour operators, health consultancy services, and also trades in medical equipment. The company has only one reportable Business Segment, which is Healthcare Services and Trading in its related products. Geographically, the company derives revenue from India, Uganda, Tanzania, Nigeria, the UAE, and Mauritius.
58GF Score
Get the complete analysis for NSE:UNIHEALTH
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNIHEALTH has been successfully added to your 
